APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Coagulation Factor VIII

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.

Selected research

Industry Growth & Trends

Global Human Coagulation Factor VIII Industry Growth and Trends Forecast to 2032

8 January 2026108 pages

Choose your research edition.

Industry ResearchHuman Coagulation Factor VIII Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Coagulation Factor VIII Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Human Coagulation Factor VIII Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Coagulation Factor VIII Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Coagulation Factor VIII Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.

Global Human Coagulation Factor VIII key players include Baxter, Bayer, CSL, Pfizer, Biogen, etc. Global top five manufacturers hold a share about 80%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 30 percent. In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%. And in terms of application, the largest application is Hemophilia A, followed by Spontanous / Trauma, Surgical, etc.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Human Coagulation Factor VIII market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Coagulation Factor VIII market size, estimates, and forecasts are presented in terms of sales volume (K Bottles) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Coagulation Factor VIII market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Coagulation Factor VIII.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Coagulation Factor VIII market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Coagulation Factor VIII Market by Company

Shire (Baxter)

Bayer

CSL

Pfizer

Grifols

Biogen

Octapharma

NovoNordisk

Greencross

Kedrion

BPL

Hualan Bio

RAAS

Human Coagulation Factor VIII Segment by Type

Recombinant Factor VIII

Plasma-derived Factor VIII

Human Coagulation Factor VIII Segment by Application

Hemophilia A

Spontanous / Trauma

Surgical

Other

Human Coagulation Factor VIII Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Coagulation Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Recombinant Factor VIII Table 2. Major Company of Plasma-derived Factor VIII Table 3. Global Human Coagulation Factor VIII Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 5. Global Human Coagulation Factor VIII Sales Market Share in Volume by Type (2021-2026) Table 6. Global Human Coagulation Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 7. Global Human Coagulation Factor VIII Sales Market Share in Value by Type (2021-2026) Table 8. Global Human Coagulation Factor VIII Price by Type (2021-2026) & (USD/Bottle) Table 9. Global Human Coagulation Factor VIII Sales by Type (2027-2032) & (K Bottles) Table 10. Global Human Coagulation Factor VIII Sales Market Share in Volume by Type (2027-2032) Table 11. Global Human Coagulation Factor VIII Sales by Type (2027-2032) & (US$ Million) Table 12. Global Human Coagulation Factor VIII Sales Market Share in Value by Type (2027-2032) Table 13. Global Human Coagulation Factor VIII Price by Type (2027-2032) & (USD/Bottle) Table 14. North America Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 15. North America Human Coagulation Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 17. Europe Human Coagulation Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 19. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 21. Latin America Human Coagulation Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 23. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 24. Human Coagulation Factor VIII Industry Trends Table 25. Human Coagulation Factor VIII Industry Drivers Table 26. Human Coagulation Factor VIII Industry Opportunities and Challenges Table 27. Human Coagulation Factor VIII Industry Restraints Table 28. Global Human Coagulation Factor VIII Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Human Coagulation Factor VIII Revenue Market Share by Company (2021-2026) Table 30. Global Human Coagulation Factor VIII Sales by Company (2021-2026) & (K Bottles) Table 31. Global Human Coagulation Factor VIII Sales Share by Company (2021-2026) Table 32. Global Human Coagulation Factor VIII Market Price by Company (2021-2026) & (USD/Bottle) Table 33. Global Human Coagulation Factor VIII Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Human Coagulation Factor VIII Major Company Production Sites and Headquarters Table 35. Global Human Coagulation Factor VIII Company, Product Type & Application Table 36. Global Human Coagulation Factor VIII Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Human Coagulation Factor VIII Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Human Coagulation Factor VIII Sales by Region (2021-2026) & (K Bottles) Table 41. Global Human Coagulation Factor VIII Sales Market Share in Volume by Region (2021-2026) Table 42. Global Human Coagulation Factor VIII Sales by Region (2021-2026) & (US$ Million) Table 43. Global Human Coagulation Factor VIII Sales Market Share in Value by Region (2021-2026) Table 44. Global Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 45. Global Human Coagulation Factor VIII Sales by Region (2027-2032) & (K Bottles) Table 46. Global Human Coagulation Factor VIII Sales Market Share in Volume by Region (2027-2032) Table 47. Global Human Coagulation Factor VIII Sales by Region (2027-2032) & (US$ Million) Table 48. Global Human Coagulation Factor VIII Sales Market Share in Value by Region (2027-2032) Table 49. Global Human Coagulation Factor VIII Sales (K Bottles), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2027-2032) Table 50. Global Human Coagulation Factor VIII Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 52. Global Human Coagulation Factor VIII Sales Market Share in Volume by Application (2021-2026) Table 53. Global Human Coagulation Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 54. Global Human Coagulation Factor VIII Sales Market Share in Value by Application (2021-2026) Table 55. Global Human Coagulation Factor VIII Price by Application (2021-2026) & (USD/Bottle) Table 56. Global Human Coagulation Factor VIII Sales by Application (2027-2032) & (K Bottles) Table 57. Global Human Coagulation Factor VIII Sales Market Share in Volume by Application (2027-2032) Table 58. Global Human Coagulation Factor VIII Sales by Application (2027-2032) & (US$ Million) Table 59. Global Human Coagulation Factor VIII Sales Market Share in Value by Application (2027-2032) Table 60. Global Human Coagulation Factor VIII Price by Application (2027-2032) & (USD/Bottle) Table 61. North America Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 62. North America Human Coagulation Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 64. Europe Human Coagulation Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 66. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 68. Latin America Human Coagulation Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 70. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 71. Shire (Baxter) Company Information Table 72. Shire (Baxter) Business Overview Table 73. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 74. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio Table 75. Shire (Baxter) Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 79. Bayer Human Coagulation Factor VIII Product Portfolio Table 80. Bayer Recent Development Table 81. CSL Company Information Table 82. CSL Business Overview Table 83. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 84. CSL Human Coagulation Factor VIII Product Portfolio Table 85. CSL Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 89. Pfizer Human Coagulation Factor VIII Product Portfolio Table 90. Pfizer Recent Development Table 91. Grifols Company Information Table 92. Grifols Business Overview Table 93. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 94. Grifols Human Coagulation Factor VIII Product Portfolio Table 95. Grifols Recent Development Table 96. Biogen Company Information Table 97. Biogen Business Overview Table 98. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 99. Biogen Human Coagulation Factor VIII Product Portfolio Table 100. Biogen Recent Development Table 101. Octapharma Company Information Table 102. Octapharma Business Overview Table 103. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 104. Octapharma Human Coagulation Factor VIII Product Portfolio Table 105. Octapharma Recent Development Table 106. NovoNordisk Company Information Table 107. NovoNordisk Business Overview Table 108. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 109. NovoNordisk Human Coagulation Factor VIII Product Portfolio Table 110. NovoNordisk Recent Development Table 111. Greencross Company Information Table 112. Greencross Business Overview Table 113. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 114. Greencross Human Coagulation Factor VIII Product Portfolio Table 115. Greencross Recent Development Table 116. Kedrion Company Information Table 117. Kedrion Business Overview Table 118. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 119. Kedrion Human Coagulation Factor VIII Product Portfolio Table 120. Kedrion Recent Development Table 121. BPL Company Information Table 122. BPL Business Overview Table 123. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 124. BPL Human Coagulation Factor VIII Product Portfolio Table 125. BPL Recent Development Table 126. Hualan Bio Company Information Table 127. Hualan Bio Business Overview Table 128. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 129. Hualan Bio Human Coagulation Factor VIII Product Portfolio Table 130. Hualan Bio Recent Development Table 131. RAAS Company Information Table 132. RAAS Business Overview Table 133. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 134. RAAS Human Coagulation Factor VIII Product Portfolio Table 135. RAAS Recent Development Table 136. North America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2021 VS 2025 VS 2032 Table 137. North America Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 138. North America Human Coagulation Factor VIII Sales Market Share by Country (2021-2026) Table 139. North America Human Coagulation Factor VIII Sales Forecast by Country (2027-2032) & (K Bottles) Table 140. North America Human Coagulation Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 141. North America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Human Coagulation Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Human Coagulation Factor VIII Market Share by Country (2021-2026) Table 144. North America Human Coagulation Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Human Coagulation Factor VIII Market Share Forecast by Country (2027-2032) Table 146. Europe Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2021 VS 2025 VS 2032 Table 147. Europe Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 148. Europe Human Coagulation Factor VIII Sales Market Share by Country (2021-2026) Table 149. Europe Human Coagulation Factor VIII Sales Forecast by Country (2027-2032) & (K Bottles) Table 150. Europe Human Coagulation Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Human Coagulation Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Human Coagulation Factor VIII Market Share by Country (2021-2026) Table 154. Europe Human Coagulation Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Human Coagulation Factor VIII Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 158. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Human Coagulation Factor VIII Sales Forecast by Country (2027-2032) & (K Bottles) Table 160. Asia-Pacific Human Coagulation Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Human Coagulation Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Human Coagulation Factor VIII Market Share by Country (2021-2026) Table 164. Asia-Pacific Human Coagulation Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Human Coagulation Factor VIII Market Share Forecast by Country (2027-2032) Table 166. Latin America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2021 VS 2025 VS 2032 Table 167. Latin America Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 168. Latin America Human Coagulation Factor VIII Sales Market Share by Country (2021-2026) Table 169. Latin America Human Coagulation Factor VIII Sales Forecast by Country (2027-2032) & (K Bottles) Table 170. Latin America Human Coagulation Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Human Coagulation Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Human Coagulation Factor VIII Market Share by Country (2021-2026) Table 174. Latin America Human Coagulation Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Human Coagulation Factor VIII Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (K Bottles): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 178. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Human Coagulation Factor VIII Sales Forecast by Country (2027-2032) & (K Bottles) Table 180. Middle East and Africa Human Coagulation Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Human Coagulation Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Human Coagulation Factor VIII Market Share by Country (2021-2026) Table 184. Middle East and Africa Human Coagulation Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Human Coagulation Factor VIII Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Human Coagulation Factor VIII Distributors List Table 189. Human Coagulation Factor VIII Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Human Coagulation Factor VIII Image Figure 2. Global Human Coagulation Factor VIII Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Coagulation Factor VIII Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Coagulation Factor VIII Sales (2021-2032) & (K Bottles) Figure 5. Recombinant Factor VIII Image Figure 6. Global Recombinant Factor VIII Sales YoY Growth (2021-2032) & (K Bottles) Figure 7. Plasma-derived Factor VIII Image Figure 8. Global Plasma-derived Factor VIII Sales YoY Growth (2021-2032) & (K Bottles) Figure 9. Global Human Coagulation Factor VIII Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Human Coagulation Factor VIII Market Share by Type 2025 VS 2032 Figure 11. North America Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2025 Figure 12. North America Human Coagulation Factor VIII Sales Market Share in Value by Type in 2025 Figure 13. Europe Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2025 Figure 14. Europe Human Coagulation Factor VIII Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Value by Type in 2025 Figure 17. Latin America Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Human Coagulation Factor VIII Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Human Coagulation Factor VIII Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hemophilia A Image Figure 24. Global Hemophilia A Sales YoY Growth (2021-2032) & (K Bottles) Figure 25. Spontanous / Trauma Image Figure 26. Global Spontanous / Trauma Sales YoY Growth (2021-2032) & (K Bottles) Figure 27. Surgical Image Figure 28. Global Surgical Sales YoY Growth (2021-2032) & (K Bottles) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Bottles) Figure 31. Global Human Coagulation Factor VIII Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Human Coagulation Factor VIII Market Share by Application 2025 VS 2032 Figure 33. North America Human Coagulation Factor VIII Sales Market Share in Volume by Application in 2025 Figure 34. North America Human Coagulation Factor VIII Sales Market Share in Value by Application in 2025 Figure 35. Europe Human Coagulation Factor VIII Sales Market Share in Volume by Application in 2025 Figure 36. Europe Human Coagulation Factor VIII Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Human Coagulation Factor VIII Sales Market Share in Value by Application in 2025 Figure 39. Latin America Human Coagulation Factor VIII Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Human Coagulation Factor VIII Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Human Coagulation Factor VIII Sales Market Share in Value by Application in 2025 Figure 43. North America Human Coagulation Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (K Bottles) Figure 44. North America Human Coagulation Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Human Coagulation Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Human Coagulation Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Coagulation Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (K Bottles) Figure 48. Europe Human Coagulation Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Coagulation Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Human Coagulation Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Human Coagulation Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (K Bottles) Figure 52. Asia-Pacific Human Coagulation Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Coagulation Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Human Coagulation Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Human Coagulation Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (K Bottles) Figure 56. Latin America Human Coagulation Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Coagulation Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Human Coagulation Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Human Coagulation Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (K Bottles) Figure 60. Middle East and Africa Human Coagulation Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Coagulation Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Human Coagulation Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Human Coagulation Factor VIII Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Human Coagulation Factor VIII Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Factor VIII
  • Plasma-derived Factor VIII
Applications
  • Hemophilia A
  • Spontanous / Trauma
  • Surgical
  • Other
Companies covered
  • Shire (Baxter)
  • Bayer
  • CSL
  • Pfizer
  • Grifols
  • Biogen
  • Octapharma
  • NovoNordisk
  • Greencross
  • Kedrion
  • BPL
  • Hualan Bio
  • RAAS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Coagulation Factor VIII Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Coagulation Factor VIII Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Coagulation Factor VIII Market by Type
  6. 1.3.1 Recombinant Factor VIII
  7. 1.3.2 Plasma-derived Factor VIII
  8. 1.4 Global Human Coagulation Factor VIII Market Size by Type
  9. 1.4.1 Global Human Coagulation Factor VIII Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Human Coagulation Factor VIII Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Human Coagulation Factor VIII Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Human Coagulation Factor VIII Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Human Coagulation Factor VIII Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Human Coagulation Factor VIII Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Human Coagulation Factor VIII Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Human Coagulation Factor VIII Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Coagulation Factor VIII Industry Trends
  2. 2.2 Human Coagulation Factor VIII Industry Drivers
  3. 2.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
  4. 2.4 Human Coagulation Factor VIII Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Coagulation Factor VIII Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Coagulation Factor VIII Sales (2021-2026)
  3. 3.3 Global Top Players by Human Coagulation Factor VIII Price (2021-2026)
  4. 3.4 Global Human Coagulation Factor VIII Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Coagulation Factor VIII Major Company Production Sites & Headquarters
  6. 3.6 Global Human Coagulation Factor VIII Company, Product Type & Application
  7. 3.7 Global Human Coagulation Factor VIII Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Coagulation Factor VIII Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Coagulation Factor VIII Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Coagulation Factor VIII Tier 1, Tier 2, and Tier 3
4 Human Coagulation Factor VIII Regional Status and Outlook
  1. 4.1 Global Human Coagulation Factor VIII Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Coagulation Factor VIII Historic Market Size by Region
  3. 4.2.1 Global Human Coagulation Factor VIII Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Coagulation Factor VIII Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Coagulation Factor VIII Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Coagulation Factor VIII Forecasted Market Size by Region
  7. 4.3.1 Global Human Coagulation Factor VIII Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Coagulation Factor VIII Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Coagulation Factor VIII Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Coagulation Factor VIII by Application
  1. 5.1 Human Coagulation Factor VIII Market by Application
  2. 5.1.1 Hemophilia A
  3. 5.1.2 Spontanous / Trauma
  4. 5.1.3 Surgical
  5. 5.1.4 Other
  6. 5.2 Global Human Coagulation Factor VIII Market Size by Application
  7. 5.2.1 Global Human Coagulation Factor VIII Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Human Coagulation Factor VIII Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Human Coagulation Factor VIII Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Human Coagulation Factor VIII Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Human Coagulation Factor VIII Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Human Coagulation Factor VIII Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Human Coagulation Factor VIII Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Human Coagulation Factor VIII Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shire (Baxter)
  2. 6.1.1 Shire (Baxter) Company Information
  3. 6.1.2 Shire (Baxter) Business Overview
  4. 6.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
  6. 6.1.5 Shire (Baxter) Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 CSL
  14. 6.3.1 CSL Company Information
  15. 6.3.2 CSL Business Overview
  16. 6.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CSL Human Coagulation Factor VIII Product Portfolio
  18. 6.3.5 CSL Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Grifols
  26. 6.5.1 Grifols Company Information
  27. 6.5.2 Grifols Business Overview
  28. 6.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
  30. 6.5.5 Grifols Recent Developments
  31. 6.6 Biogen
  32. 6.6.1 Biogen Company Information
  33. 6.6.2 Biogen Business Overview
  34. 6.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
  36. 6.6.5 Biogen Recent Developments
  37. 6.7 Octapharma
  38. 6.7.1 Octapharma Company Information
  39. 6.7.2 Octapharma Business Overview
  40. 6.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
  42. 6.7.5 Octapharma Recent Developments
  43. 6.8 NovoNordisk
  44. 6.8.1 NovoNordisk Company Information
  45. 6.8.2 NovoNordisk Business Overview
  46. 6.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
  48. 6.8.5 NovoNordisk Recent Developments
  49. 6.9 Greencross
  50. 6.9.1 Greencross Company Information
  51. 6.9.2 Greencross Business Overview
  52. 6.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
  54. 6.9.5 Greencross Recent Developments
  55. 6.10 Kedrion
  56. 6.10.1 Kedrion Company Information
  57. 6.10.2 Kedrion Business Overview
  58. 6.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
  60. 6.10.5 Kedrion Recent Developments
  61. 6.11 BPL
  62. 6.11.1 BPL Company Information
  63. 6.11.2 BPL Business Overview
  64. 6.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 BPL Human Coagulation Factor VIII Product Portfolio
  66. 6.11.5 BPL Recent Developments
  67. 6.12 Hualan Bio
  68. 6.12.1 Hualan Bio Company Information
  69. 6.12.2 Hualan Bio Business Overview
  70. 6.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
  72. 6.12.5 Hualan Bio Recent Developments
  73. 6.13 RAAS
  74. 6.13.1 RAAS Company Information
  75. 6.13.2 RAAS Business Overview
  76. 6.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
  78. 6.13.5 RAAS Recent Developments
7 North America by Country
  1. 7.1 North America Human Coagulation Factor VIII Sales by Country
  2. 7.1.1 North America Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Coagulation Factor VIII Sales by Country (2021-2026)
  4. 7.1.3 North America Human Coagulation Factor VIII Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Coagulation Factor VIII Market Size by Country
  6. 7.2.1 North America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Coagulation Factor VIII Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Coagulation Factor VIII Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Coagulation Factor VIII Sales by Country
  2. 8.1.1 Europe Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Coagulation Factor VIII Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Coagulation Factor VIII Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Coagulation Factor VIII Market Size by Country
  6. 8.2.1 Europe Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Coagulation Factor VIII Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Coagulation Factor VIII Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Coagulation Factor VIII Sales by Country
  2. 9.1.1 Asia-Pacific Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Coagulation Factor VIII Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Coagulation Factor VIII Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Coagulation Factor VIII Market Size by Country
  6. 9.2.1 Asia-Pacific Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Coagulation Factor VIII Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Coagulation Factor VIII Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Coagulation Factor VIII Sales by Country
  2. 10.1.1 South America Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Coagulation Factor VIII Sales by Country (2021-2026)
  4. 10.1.3 South America Human Coagulation Factor VIII Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Coagulation Factor VIII Market Size by Country
  6. 10.2.1 South America Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Coagulation Factor VIII Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Coagulation Factor VIII Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Coagulation Factor VIII Sales by Country
  2. 11.1.1 Middle East and Africa Human Coagulation Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Coagulation Factor VIII Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Coagulation Factor VIII Market Size by Country
  6. 11.2.1 Middle East and Africa Human Coagulation Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Coagulation Factor VIII Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Coagulation Factor VIII Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Coagulation Factor VIII Value Chain Analysis
  2. 12.1.1 Human Coagulation Factor VIII Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Coagulation Factor VIII Production Mode & Process
  7. 12.2 Human Coagulation Factor VIII Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Coagulation Factor VIII Distributors
  10. 12.2.3 Human Coagulation Factor VIII Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst